Media advisory - Government of Canada to announce major milestone achieved in Canadian biomanufacturing and life sciences sector
LAVAL, QC, Feb. 22, 2024 /CNW/ - The Honourable François-Philippe Champagne, Minister of Innovation, Science and Industry, the Honourable Mark Holland, Minister of Health, and the Honourable Jean-Yves Duclos, Minister of Public Services and Procurement, as well as Pierre Fitzgibbon, Quebec Minister of Economy, Innovation and Energy, Minister Responsible for Regional Economic Development and Minister Responsible for the Metropolis and the Montréal Region, Christopher Skeete, Quebec Minister for the Economy, Minister Responsible for the Fight Against Racism and Minister Responsible for the Laval Region, and Stéphane Boyer, Mayor of Laval, will mark a major milestone for Moderna's new state-of-the-art mRNA vaccine production facility in Laval, Quebec, with a tour of the facility for dignitaries and media representatives, followed by a media scrum.
Date: Friday, February 23, 2024
Time: 10:00 am to noon
Note for media Members of the media are asked to contact ISED Media Relations at [email protected] to confirm their attendance and receive event location details.
Smart Meter, the leading supplier of Cellular Remote Patient Monitoring (RPM)tm solutions, has introduced a new version of the iGlucose, its patented cellular-connected glucose meter used by over 200,000 people with diabetes since 2019. The...
Today, the Honourable Gary Anandasangaree, Minister of Crown-Indigenous Relations; the Honourable Patty Hajdu, Minister of Indigenous Services and Minister responsible for FedNor; the Honourable Dan Vandal, Minister of Northern Affairs; and the...
GE HealthCare today unveiled SIGNA MAGNUS, an FDA 510(k) pending head-only magnetic resonance (MR) scanner designed to explore advancements in neuroscience, which have been restricted by the performance limitations of conventional whole-body MR...
To mark National Hospice Palliative Care Week, the Quebec Coalition for Palliative Care Access (the Coalition) is proud to celebrate the positive impact of palliative care on the well-being of people with life-limiting illness.
Palliative care is...
A native born and trained Brazilian oncologist is in the forefront of a new era in the treatment of cancer patients with cutting edge proton therapy medical technology developed in Israel by P-Cure.
"It is my dream to be able to bring the P-Cure...
UroGen Pharma Ltd. , a biotech company dedicated to developing and commercializing innovative solutions that treat urothelial and specialty cancers, today announced results from a new analysis of the ATLAS trial, which estimates using Kaplan Meier...